← brief for 2026-09-21 · Slowing decline

Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD

Paper C Peer reviewed Observational

Key takeaways

This study checked the safety of a common diabetes drug in people with kidney disease. It looked for side effects in a large group of patients. This is an observational study, so it shows a link, not proof of cause.

Source

Paper · AJKD · 2026-09-20
https://www.ajkd.org/article/S0272-6386(26)01118-2/fulltext?rss=yes